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Objective: To evaluate the role of MRI in differentiation of benign from malignant breast lesions using
dynamic contrast enhanced MRI (DCE-MRI) and diffusion weighted MRI (DW-MRI).
Patients and methods: The study included 33 female patients with clinically suspicious breast lesions
detected by mammography and/or breast ultrasound. Cases were referred from general surgery
departments in Tanta university hospital. The patients underwent full history taking and clinical
examination, full field digital mammography and US, for those patients cases diagnosed on
sonomammography as BI-RADS 3 & 4 were selected for MRI examination.
Results: Quantitative analysis of DWI was done for the 33 breast lesions and their ADC values are
recorded at 3 different b-values (250, 600, and 1000). Seventeen lesions showed facilitated diffusion,
proved to be benign and 10 lesions showed restricted diffusion, 9 lesions of them proved to be malignant
and one proved to be benign. There are 6 lesions showed mixed restricted and facilitated diffusion proved
to be malignant.
Conclusion: DWI improves the diagnostic ability of the DCE-MRI of the breast. It is a better method for
detecting breast lesions than either T1- or T2-weighted imaging, but it is better to be performed in con-
junction with contrast enhanced MRI.
 2017 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Breast cancer is now a significant cause of worldwide morbid-
ity and mortality. Further, the increasing rate of breast cancer
continues to be a major area of concern for both clinicians and
researchers. Increased awareness in the affected population leads
to more frequent physical examinations and diagnostic imaging
procedures which results in earlier diagnosis and hence improved
prognosis.1
Nowadays MRI of the breast is frequently applied when other
diagnostic modalities fail to find a primary source in the breast,
remarkable advances in MRI technology have allowed sensitive
detection and anatomic definition of cancer, and the introduction
of MRI in several aspects of breast cancer diagnosis and
management.2Dynamic contrast-enhanced MRI (DCE-MRI) and diffusion
weighted MRI (DW-MRI) are currently used as an adjunct to mam-
mography in women at high risk, or those with extremely dense
breasts, selective ‘‘problem-solving” or adjunct diagnosis where
standard clinical and imaging evaluation do not provide a clear
diagnosis, imaging of breast silicone implants, monitoring
response to neoadjuvant (primary), systemic therapy in locally
advanced disease, irradiated breasts, and postsurgical breasts or
highly invasive breast cancers.3
In addition, using DWI & ADC values are reportedly useful in
differentiating benign from malignant breast lesions and in the
detection of breast cancer without administration of contrast med-
ium. Hence, DWI could be a promising tool in screening for breast
cancer without using contrast medium, especially for patients with
renal dysfunction or previous reactions to contrast agents and will
relieve the cost of examination.4,5
The aim of the study was to evaluate the role of the magnetic
resonance imaging in differentiation of benign from malignant
breast lesions using dynamic contrast enhanced MRI (DCE-MRI)
and diffusion weighted MRI (DW-MRI).
Table 3
The MR enhancement characteristics of mass and non mass lesions.
MRI findings No. of enhanced breast lesions
Homogenous Heterogeneous
No. benign lesions 12 (66.67%) 0
No. of malignant lesions 9 (60%) 6a (40%)
Total no. of patients 21 6
P-value 0.000460827.
a Including 3 non mass lesions.
b Including 3 non mass lesions.
Table 4
Shows the type of time/signal intensity curve of 27 enhanced breast lesions.
DCE-MRI Type of time signal intensity curve
Type 1 (Persistent) Type
No. of benign lesions 3(25%) 9(75
No. of malignant lesions* 0 0
Total no. of enhanced breast lesions 3 (11.11%) 9 (22
P-value < 0.00001.
* Six cases were found to have more than one time /signal intensity curve type.
Table 1
BIRADS descriptor criteria by MRI of studied 27 mass breast lesions.
MRI findings No. of patients with
benign lesions
No. of patients with
malignant lesions
Shape
- Round 9 0
- Oval 6 0
- Lobular 0 3
- Irregular 0 9
Margin
- smooth 15 0
- irregular 0 9
- speculated 0 3
Mass enhancement
- homogenous 9 9
- heterogeneous 3 3
- rim 0 0




- central enhancement 0 0
- non enhanced 3 0
Kinetic curve assessment
- initial rise (slow-
medium-rapid)
15* 12
- delayed phase (plateau
persistent-washout)
* There are 3 benign lesions not enhanced.
Table 2
BIRADS descriptor criteria by MRI of studied 6 non mass breast lesions.
MRI findings No. of benign lesions No. of malignant lesions
Distribution modifiers
- focal area 3 0
- linear 0 0
- ductal 0 0
- segmental 0 0
- regional 0 3
- multiple regions 0 0
- diffuse 0 0
Internal enhancement
- homogenous 0* 0
- heterogeneous 0 3
- stippled, punctuate 0 0
- clumped 0 0
- reticular, dendritic 0 0
P-value < 0.0001.
* The 3 benign lesions are not enhanced.
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The current study included 33 female patients with clinically
suspicious breast lesions detected by mammography and/or breast
ultrasound; their age range was 30 & 65 years. The study was con-
ducted in Tanta university hospital during the period from March
2013 to April 2015. Cases were referred from general surgery
departments in Tanta university hospital. The patients underwent
full history taking and clinical examination, full field digital mam-
mography and US, for those patients cases diagnosed on sonomam-
mography as BI-RADS 3 & 4 were selected for MRI examination.
Patients were excluded from the study in case of contraindica-
tions to perform MRI, (patients with metallic foreign body or car-
diac pacemakers, claustrophobic and uncooperative patients,
patients could not lie prone, patients who were allergic to contrast
media, patients with disturbed renal functions and patients who
refused the examination).
An informed consent was obtained from patients included in
the study; an approval was obtained from the ethics committee.
Magnetic resonance imaging, dynamic contrast enhanced MRI
was performed for the 33 patients included in the study with high
field strength 1.5 T on high signa (general electric medical system)
high speed using dedicated double breast coil.
Patient preparation: All metallic subjects were far from the
patient body including zippers and clasps. Intravenous line
was established for further gadolinium injection.
Patient positioning: The patient lied prone with breasts posi-
tioned onto the breast coil and checked to be as deep and as
centered in the coil as possible, with the nipple faced straight
down. The patient comfortability was checked and patients




Total no. of breast lesions
2 (Plateau) Type 3 (washout)
%) 0 12
15 (100%) 15
.22%) 15 (55.56%) 27
Table 5
classification of the examined 33 breast lesions according to their criteria on DW-MRI.







Benign 12 6 18






Classification of the examined 33 breast lesions according to their criteria on unenhanced breast MRI.
DWI-MRI findings Lesions with restricted diffusion Lesions with facilitated diffusion Lesions with mixed restricted & facilitated diffusion Total No. of lesions
Benign 1 (5.6%) 17 (94.4%) 0 18
Malignant 9 (60%) 0 6 (40%) 15
Total no. of lesions 10 (30.3%) 17 (51.5%) 6 (18.2%) 33
P-value 0.0004.
Table 7
Final assessment BI-RADS category of the 33 studied female patients with breast lesions.
Final assessment category No. of patients with benign lesions No. of patients with malignant lesions Total
Category 2 3 0 3 9.1%
Category 3 15 0 15 45.45%
Category 4 0 9 9 27.27%
Category 5 0 6 6 18.18%
Total no. of patients 18 15 33 100%
P-value < 0.000001.
Figure 1. MRI STIRWI (A): of the left breast revealed well defined abnormal signal intensity at the deep retroareolar region with heterogeneous signal intensity. DCE-MRI (B):
revealed the retroareolar lesion not enhanced. DW-MRI with post processing ADC maps at b-values 600 (C& D) & 1000 (E & F) : revealed facilitated diffusion of the lesion with
ADC value of region of interest 1.7  103 mm2/s confirming benignity.MRI scanning : BI-RADS category 2. Follow up of the patient after 6 months revealed no abnormality.
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Figure 2. MRI T1WI, T2WI & STIRWI (A–C): revealed bilateral multiple lesions with low signal intensity in T1WI, high signal intensity in T2WI & STIRWI. DCE-MRI (D):
revealed non enhancement of the lesions. DW-MRI with post processing ADCmaps at b-values 250 (E, F), 600 (G, H): revealed facilitated diffusion of the lesion with ADC value
of region of interest 1.8  103 mm2/s confirming benignity.MRI scanning: BI-RADS category 2. The patient subjected to follow up after 6 months and no change occur.
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localization purpose and followed by plain sequences using
T1weighted fast spin echo sequence (TR = 501 ms, TE = 10 ms,
FOV = 24  24 cm),in addition to T2 weighted fast spin echo
sequence (TR = 4131 ms, TE = 120 ms, FOV = 36  28 cm) & STIR
weighted fast spin echo sequence (TR = 3660 ms, TE = 103 ms,
FOV = 36  23.4 cm) in axial orientation and/or sagittal
orientation.
A bolus of gadolinium dimeglumine (Gd-DTPA) was injected
manually intravenous at a dose of (0.1 mmol/kg) followed by saline
flush to ensure that contrast – enhanced images could be obtained
immediately after contrast agent injection.Figure 3. MRI STIRWI (A): of both breasts revealed LT breast isointense lesion with centr
intensity curve (C): of the left breast lesion showed rim-enhanced mass with a thick wall
up and rapid wash out (curve type III) DW-MRI with post processing ADC maps at b-valu
corresponding ADC map shows the ADC value of the wall is 1.04  103 mm2/s, the c
biobsied and the biobsy revealed invasive ductal carcinoma.DWI was performed using a diffusion-weighted echo-planar
imaging (EPI) sequence with parallel imaging (GE machine); reduc-
tion factor, 2; 7,000/71.5; number of excitations, 2; matrix,
240  240; field of view, 34 cm; slice thickness, 3 mm; and gap,
0. Diffusion gradients were applied in six directions with b
value = 600 and 1000 s/mm2, and the scanning time was 4 min.
Respiratory triggering was used for better resolution.
Image post processing on the work station: Diffusion maps
were formed. A noise-level threshold of 200 was applied to mask
the b = 0 s/mm2 images before forming diffusion maps.
An ROI was defined for each DCE-MRI–detected lesion at
the corresponding location on the combined DWI (SDWI) series.al hyperintensity with surrounding prepectoral oedema. DCE-MRI (B) & time/signal
and smooth margin, its time signal intensity curve of the lesion showed rapid slope
es 600 (D, E) & 1000 (F, G): the mass showed peripheral hyperintensity on DWI. The
entral part, 2.70  103 mm2/s MRI scanning: BI-RADS category 5. The lesion was
Fig. 3 (continued)
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lesion. Quantitative analysis was done by placing the ROI at the
most enhanced part within the lesion result in automatically
created time/ signal intensity curve.2.1. Image analysis
The MRI images were evaluated as follow: T1 weighted images,
T2 weighted images and STIR weighted images were first exam-
ined to detect presence of any abnormality, determination of MR
appearance of the lesion(cystic, solid or mixed), location of the
lesion, definition of the lesion (well or ill-defined), signal intensity
of the lesion, the presence of lymph nodes.
Dynamic contrast enhanced images were examined to
detect the presence or absence of lesion enhancement. Lesions
interpretation took place as follow :Its shape (regular or irregular
(,its border (well defined, ill defined, speculated, pattern of
enhancement (homogenous, heterogeneous or ring enhancement
(, dynamic behavior of the mass with evaluation of the percentageof enhancement as well as the shape of time/signal intensity curve
(type I, type II or type III) was studied.
Diffusion – weighted images and ADC maps are then examined
and the mean ADC of each lesion. The quantitative analysis of DWI,
we generated the ADC maps from the DWI from b values (600 and
1000), then ADC values are automatically calculated on the work
station.
MRI BIRADS classification was applied for each lesion based on
the combination of morphologic and kinetic criteria, there were
not any cases categorized as BI-RADS category I, Lesions that cate-
gorized as BI-RADS category 2 & 3 subjected to follow up after
6 months while lesions categorized as BI-RADS category 4 & 5 were
correlated with histopathological result.
2.2. Statistical analysis
The role of MRI (DWI & DCE-MRI) in detection and characteriza-
tion of breast focal lesions was evaluated and compared with
histopathology (for fifteen cases) and multi-modality with clinical
follow-up (for the remaining eighteen cases) which were
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described in terms of range, mean ± standard deviation (±SD), fre-
quencies (number of cases) and percentages when appropriate.
Data entry was done by SPSS version 16 and analyzed by the same
software. The final diagnosis was confirmed by follow up after
6 months in 18 female patients whom classified as BI-RADS cate-
gory 2 and 3 as the patients with BI-RADS category 2 had past his-
tory of breast cancer. The final diagnosis was confirmed by FNAC in
15 female patients whom classified as BI-RADS category 4 and 5.3. Results
All the 33 patients included in the study which their ultrasound
and/or mammography were suspicious besides their suspicious
past history were referred for MRI examination. Description of
MRI findings using BI-RADS included, the lesion type if mass or
non- mass lesions. Regarding the mass lesions, the description
including basic morphological criteria of solid mass lesions includ-
ing shape, margin, mass enhancement and the kinetic curve assess-
ment. The number of mass lesions in our study was 27 lesions (as
shown in Table 1).Figure 4. MRI STIRWI (A): of both breasts revealed RT breast hyperintense lesion with
lesion showed rim-enhanced mass with irregular margin with time signal intensity curve
benignity. DW-MRI with post processing ADC maps at b-values 600 (D&E) & 1000 (F&G):
the ADC value of the wall is 1.33  103 mm2/s, the central part, 0.861  103 mm2/s. MThere are 6 non- mass lesions in our study. The BI-RADS
description applied for the non mass lesions included, distribution
modifiers and the internal enhancement characteristics (as shown
in Table 2).
Dynamic contrast enhanced MRI showed 33 mass and non mass
breast lesions, 21 lesions showed homogenous enhancement, 12 of
them were benign and the other 9 lesions were malignant. Six
lesions showed heterogeneous enhancement all of them were
malignant. Six lesions were not enhanced; all of them were benign
(as shown in Table 3).
In this study the 27 enhanced breast lesions, their time signal
intensity curve were assessed, regarding their initial rise (slow,
medium or rapid) and their delayed phase (persistent, plateau or
washout). DCE-MRI revealed 3 lesions with progressive rising
time/signal intensity curve (type I curve). Nine lesions showed
slow wash in, slow wash out with plateau curve (type 2 curve).
Nine lesions showed rapid slope up and rapid wash out (type 3
curve). There are 6 lesions showed more than one type of time/sig-
nal intensity curve, 3 lesions of those 6 lesions showed type 2 and
type 3 curves, other 3 lesions showed the three types of curves (as
shown in Table 4).nipple retraction .DCE-MRI(B) & time/signal intensity curve (C): of the right breast
showed gradual slow slope up with gradual enhancement (curve type 1) indicating
the mass showed central hyperintensity on DWI. The corresponding ADCmap shows
RI scanning: BI-RADS category 2.Pathology revealed lactating abscess.
Fig. 4 (continued)
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They were classified according to their criteria on unenhanced
MRI to benign and malignant lesions regarding to their signal
intensity on DWI-MRI. There were 27 which displayed as hyper
intensities on DWI-MRI, 12 of them were benign and 15 lesions
were malignant. There were 6 lesions who displayed as hypo
intensities on DWI-MRI, all of them were benign (as shown in
Table 5).
Quantitative analysis of DWI was done for the 33 breast lesions
and their ADC values are recorded at 3 different b-values (250, 600,
and 1000). Seventeen lesions showed facilitated diffusion, proved
to be benign and 10 lesions showed restricted diffusion, 9 lesions
of them proved to be malignant and one proved to be benign. There
are 6 lesions showed mixed restricted and facilitated diffusion
proved to be malignant (as shown in Table 6).
The decision of final assessment category was based on the cri-
teria of the lesions on basic MRI sequences (T1 W, T2 W, STIRW),
DCE-MRI, DWI and recorded ADC values on the ADC map (as
shown in Table 7) Figs. 1–4.4. Discussion
Dynamic contrast-enhanced MRI of the breast has high ability
for breast lesions detection. DCE-MRI is also more accurate than
mammography or ultrasound for the delineation of the extent of
disease in patients with a recent diagnosis of cancer but limited
ability for discrimination between benign and malignant lesions.6
Diffusion weighted MR imaging (DWI) has recently been
reported to demonstrate usefulness in differentiating benign from
malignant breast lesions and for monitoring treatment response
after chemotherapy or radiation, for differentiating post therapeutic
changes from residual active tumor, and for detecting recurrent
cancer.7 Potential additional roles include predicting treatment out-
comes (before and soon after starting therapy), for tumor staging,
and perhaps also for detecting lymph node involvement by cancer.8
DWI is quantified by ADC values, which is a calculated measure
of water diffusion through the tissues. ADC values vary between
malignant and benign breast lesions, whereby the ADC values of
malignant breast lesions are usually lower than those of benign
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larity. The ADC values of benign lesions are higher, reflecting nor-
mal cellularity and no restriction of water movement.
Nevertheless, there is overlap as benign breast changes can mimic
malignancies.9,10
Our study included 33 patients with 33 breast lesions to evalu-
ate the role of DWI as an adjunct to DCE-MRI in the probably
benign and suspicious breast lesions after mammographic and/or
ultrasonographic examinations. The patients included in this study
were selected according to their clinical presentation, the patient
past history, the appearance of lesion in the ultrasound or mam-
mography (suspicious lesions were selected).
The final diagnosis was confirmed by follow up after 6 months
in 18 female patients whom classified as BI-RADS category 2 and
3 as the patients with BI-RADS category 2 had past history of breast
cancer. The final diagnosis was confirmed by FNAC in 15 female
patients whom classified as BI-RADS category 4 and 5.
In this study it was found that the lesions with smooth margin
(well defined) were 15 lesions and all were benign while the
lesions with irregular and speculated margin were all malignant.
This is comparable with Macura et al. 11 who reported that the
margin description of a focal mass is the most predictive feature
of the breast MR image interpretation and speculated margin are
more suspicious for carcinoma.
In this study DCE-MRI of mass lesions was done which revealed
24 enhanced lesions and 3 non enhanced lesions. Twenty-one
lesions with homogenous enhancement 12 of them were benign
and the other 8 lesions were malignant. The lesions with heteroge-
neous enhancement were 3 lesions and all were malignant. In the
non mass lesions in the present study, 3 lesions were with focal
area of enhancement while 3 lesions were not enhanced. In the
present study, in case of mass like enhancement it was found that
the heterogeneous enhancement indicative for malignant lesions
while homogenous enhancement is likely to occur in benign
lesions While non mass lesions no specific criteria for the enhance-
ment pattern, and this confirms the study conducted by Tozaki
et al. 12 Who reported that the most frequent morphological find-
ing among the malignant lesions was heterogeneous internal
enhancement.
In the present study DCE-MRI time signal intensity curve
revealed 3 lesions showed progressive raising curve (type I curve),
by histopathology the 3 lesions were benign. 9 lesions showed pla-
teau curve (type II curve), all the 9 lesions were benign. 15 lesions
showed rapid wash out (type III curve) all proved by histopathol-
ogy as malignant. This is comparable with many studies that
reported the importance of the curve shape in differentiating
between malignant and benign lesions. The use of time- signal
intensity curves resulted in dramatically higher discrimination
between benign and malignant lesions. Type III curve is more sus-
picious for malignancy, whereas persistent curves are associated
with benign lesions. Plateau curves are indicative of either malig-
nant or benign lesions. Schnall et al. 13
In this study there was one false positive case which was on
unenhanced MRI T1WI,T2WI and STIRWI appeared well definedwith homogenous enhancement on DCE-MRI with time/signal
intensity curve of type 2 but on DWI showed restricted diffusion
with ADC value 0.7  103 mm2/s, but by histopathology proved
to be benign (fibroadenoma). So in our study the DWI technique
had false positive result, this confirms the study conducted by For-
nasa et al. 14 which during the study detect 2 false positive cases
one of them was fibroadenoma.
In this study we calculated the ADC value with two different b-
values (600 & 1000). In this study there was no any difference
between the ADC values detected at different b-values. The results
imply that to differentiate benign from malignant breast lesions.
This confirmed the study conducted by Chen et al. 15 which
reported that varying the b-values does not influence the conspicu-
ity of breast lesions on DWI at 1.5 T.
In conclusion DWI improves the diagnostic ability of the DCE-
MRI of the breast. It is a better method for detecting breast lesions
than either T1- or T2-weighted imaging, but it is better to be per-
formed in conjunction with contrast enhanced MRI.
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